David Brayden

Full Professor of Advanced Drug Delivery at University College Dublin

[David Brayden @BraydenDavid]

Our new paper from the EU's @BuccalPep consortium on oromucosal peptide delivery is out in @DDTReMedia . @ucddublin @ucdvetmed PhD student Sandeep Karki's first paper! Access at: https://t.co/BocJeTal7s. Also at: https://t.co/jbeQzaFcTj

[David Brayden @BraydenDavid]

We have a new paper out with @GattefosseGroup collaborators on Capryol 90 as an intestinal permeation enhancer. Free full text: https://t.co/8WMyItxndH

[David Brayden @BraydenDavid]

We have a new paper out in JCR with the University of Louvain in which UCD played a small part. Title: "An in situ bioadhesive foam as a large intestinal delivery platform for antibody fragments to treat inflammatory bowel disease". https://t.co/Y1keywo6a4

[David Brayden @BraydenDavid]

We have a new Open Access paper out from our Gattefosse collaboration in Int. J. Pharm: "LabrafacTM MC60 is an efficacious intestinal permeation enhancer for macromolecules: comparisons with Labrasol® ALF in ex vivo and in vivo rat studies" https://t.co/aNgn1yEcgf

[David Brayden @BraydenDavid]

We've a new open access paper out in ACS Applied Materials & Interfaces. "Reproducible Synthesis of Biocompatible Albumin Nanoparticles Designed for Intra-articular Administration of Celecoxib to Treat Osteoarthritis." doi/10.1021/acsami.4c02243. @CURAMdevices; @UCD_Conway

[David Brayden @BraydenDavid]

@Peterhouse_Cam Good to see that Peterhouse is admitting a new type of Fellow.

[David Brayden @BraydenDavid]

I am hiring a Postdoc to work on a 2-year industry-funded on intestinal permeation enhancers for fluxes of macromolecules. Ex vivo and in vivo GI bioassays will be used: Job post 016909 on the @ucddublin website https://t.co/HnvZxI8hIM. @UCD_Conway Closing date Feb 16.

[David Brayden @BraydenDavid]

We have a new open-access review out in ADDR on the safety of oral surfactants in dosage forms. https://t.co/wAZudnSky8

[David Brayden @BraydenDavid]

https://t.co/73AWH3S1vV

I have a new review article out in March Issue of American Pharmaceutical Review.

[David Brayden @BraydenDavid]

I co-authored a just-published review with FDA authors and others on excipients in oral delivery systems https://t.co/DOC9wkWFAD

[David Brayden @BraydenDavid]

I have 2 fully-funded PhD posts available each for 4 years advertised on: https://t.co/oxfgz6waEj. One is on buccal delivery of peptides and the other is on an anti-inflammatory nanoparticle for arthritis. Funded by SFI CURAM Centre for Medical Devices. Closing date: July 15.

[David Brayden @BraydenDavid]

Delighted to be awarded a grant (PEPDELIVER) on oral insulin delivery from the Shared Island "North-South" grant initiative with co-applicant Prof Helen McCarthy (QUB) and collaborator Prof Nick Dunne (DCU) .@njdunne_lab, @DCUBiodesign @Prof_H_McCarthy, @pHionTx, @UCD_Research

[David Brayden @BraydenDavid]

We have a new open-access review in oral peptide delivery from food sources out in Biomedicine and Pharmacotherapy, written with Nuritas Ltd. https://t.co/vzH59TxAqs.

[David Brayden @BraydenDavid]

New Open Access review article out in Frontiers in Drug Delivery. The Centenary of the Discovery of Insulin: An Update on the Quest for Oral Delivery https://t.co/X9p2rg5vOh

[David Brayden @BraydenDavid]

@FrontiersIn Great impact and cite numbers for Frontiers. We hope the new Frontiers in Drug Delivery journal will be adding to them in coming years.

[David Brayden @BraydenDavid]

@FrontDrugDDS @ucddublin @FrontiersIn Happy to be taking on this new role with Frontiers in Drug Delivery.

[David Brayden @BraydenDavid]

Our latest Open Access paper is out in Expert Opinion in Drug Delivery. We did a technological evaluation of Chiasma's MYCAPSSA, (oral octreotide) where we know a bit about the formulation. Copies available at: https://t.co/ICdVRDQB6a

[David Brayden @BraydenDavid]

Happy to work with @scipod_social on this, a professional podcast to achieve further outreach for our research papers.

@CURAMdevices @ucddublin #scicomm

[Scipod @scipod_social]

Professor David J. Brayden @ucddublin is dedicated to enhancing the oral delivery of peptides. His team are conducting cutting edge research on the effects of specific sugar-based monoesters as intestinal permeation enhancers: https://t.co/cuy1Pf54Tm
#scicomm

[David Brayden @BraydenDavid]

Our new paper "Synthesis and In Vivo
Evaluation of Insulin-Loaded Whey Beads as an Oral Peptide Delivery System" by Joanne Heade et al is published today in Pharmaceutics and the Open Access text is available at: https://t.co/cVfvLm8fdB

[David Brayden @BraydenDavid]

We have a new open-access paper on sugar esters as intestinal permeation enhancers published in IJP by McCartney, F et al. with great collaborators from Urbino and Nottingham. https://t.co/Q4AQx6lKML